Search

You searched for "tear"

2412 results found

Results of fixed aflibercept treatment regime in type 3 neovascularisation

1 April 2020 | | EYE - Vitreo-Retinal
In this prospective study the authors evaluate the effect of intravitreal aflibercept injections in the treatment of naive type 3 neovascularisation using a fixed treatment regime. Fourteen eyes of 14 patients were studied. All patients were treated with intravitreal 2.0...

Scope Ophthalmology announce case awards winners

11 September 2023 | Awards, Conferences & Anniversaries
Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.

SCOPE Announces 2025 Independent Prescriber Bursary Award Winners

5 August 2025 | Company Profiles, Awards, Conferences & Anniversaries
SCOPE is proud to announce the winners of its 2025 Independent Prescriber (IP) Bursary Awards, an initiative now in its fourth year. Designed to support optometrists in gaining IP qualifications by covering course fees, the awards continue to attract strong...

Surgitrac Instruments at the 43rd Congress of the ESCRS: A Successful Event in Copenhagen

22 September 2025 | Company Profiles, Awards, Conferences & Anniversaries
Surgitrac Instruments was proud to exhibit at the 43rd Congress of the ESCRS in the beautiful city of Copenhagen. This year’s congress was a fantastic opportunity to connect with ophthalmic professionals from around the world, share ideas, and showcase our...

Principles of management

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - Pathology
Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

A new observation point: updating the nomenclature and classification with OCT

3 June 2021 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
The evolution of ophthalmic imaging technologies has been particularly rapid over the last few years. The author provides an update of the current terms for common signs and pathologies observed using optical coherence tomography. My experience as an ophthalmic technician,...

A guide to utilising your time efficiently to develop clinical and procedural skills as an aspiring ophthalmologist

4 February 2025 | | EYE - General
Ophthalmology often receives limited coverage in the undergraduate medical curriculum, and the availability of foundation programme jobs in this field is also restricted, reducing exposure to this field for aspiring ophthalmologists. Even if you’re not planning to specialise in ophthalmology,...

Initiatives in macular service provision

1 December 2015 | | EYE - Vitreo-Retinal
A report from Monitor in October 2015 identifies good practices that will realise most of the potential productivity gain in elective care available to NHS hospitals. These include: stratifying patients by risk and creating low-complexity pathways for lower-risk patients (tailoring...

Time is vision in central retinal artery occlusion

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
Central retinal artery occlusion (CRAO) is a rare but devastating vascular episode that can have severe impact on vision. Treatment is very time-limited and needs to be initiated very quickly to salvage any vision. The majority of patients present to...

The extended role of the specialist ophthalmic photographer

2 August 2022 | | EYE - Imaging, EYE - General
The prevalence of certain retinal conditions such as diabetic retinopathy and age-related macular degeneration (ARMD) is projected to grow substantially over the next decades. Estimates for the projected growth in burden on eye services for diabetic retinopathy and neovascular ARMD...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...